Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K
Cell Adhesion in Plants01:14

Cell Adhesion in Plants

2.4K
Plants have rigid cell walls that are made up of cell wall polysaccharides that mediate cell-cell adhesion. The primary cell walls of plants consist of two independent and interacting polysaccharide networks: a pectin matrix that embeds the second network comprising cellulose and hemicelluloses.
Pectins are complex heteropolymers mainly composed of negatively-charged α-D-glucopyranosyl uronic acid and some neutral glycosyl residues such as α-L-rhamnopyranose, α-L-arabinofuranose,...
2.4K
Notch Signaling Pathway03:14

Notch Signaling Pathway

4.6K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.6K
Notch Signaling Pathway03:14

Notch Signaling Pathway

4.9K
4.9K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Absence of EOGT precludes defective development in fringe-null mouse intestine.

Biochimica et biophysica acta. General subjects·2026
Same author

Absence of EOGT Precludes Defective Development in Fringe-null Mouse Intestine.

bioRxiv : the preprint server for biology·2026
Same author

Absence of the dolichol synthesis gene DHRSX leads to N-glycosylation defects in Lec5 and Lec9 Chinese hamster ovary cells.

The Journal of biological chemistry·2024
Same author

Deletion of <i>Mgat2</i> in spermatogonia blocks spermatogenesis.

Frontiers in cell and developmental biology·2024
Same author

The N-glycosylation defect in Lec5 and Lec9 CHO cells is caused by absence of the DHRSX gene.

bioRxiv : the preprint server for biology·2024
Same author

Genetics of glycosylation in mammalian development and disease.

Nature reviews. Genetics·2024
Same journal

A viral ORFeome library for systems-level genetic dissection of host-pathogen interactions.

Cell·2026
Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026
Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026
Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026
Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026
Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: May 3, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

9.4K

La galectina-1 mueve las cuerdas en VEGFR2

Pamela Stanley1

  • 1Department Cell Biology, Albert Einstein College Medicine, New York, NY 10461, USA.

Cell
|February 18, 2014
PubMed
Resumen
Este resumen es generado por máquina.

La galectina-1 impulsa el crecimiento tumoral al mantener el receptor 2 del VEGF en las superficies celulares, promoviendo la formación de vasos sanguíneos independientemente del VEGF. Este descubrimiento ofrece nuevos conocimientos sobre la resistencia contra las terapias anticancerígenas anti-angiogénesis.

Más Videos Relacionados

Isolation of Murine Retinal Endothelial Cells for Next-Generation Sequencing
09:59

Isolation of Murine Retinal Endothelial Cells for Next-Generation Sequencing

Published on: October 11, 2021

3.0K
A Method for Labeling Vasculature in Embryonic Mice
09:58

A Method for Labeling Vasculature in Embryonic Mice

Published on: October 7, 2011

15.4K

Videos de Experimentos Relacionados

Last Updated: May 3, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

9.4K
Isolation of Murine Retinal Endothelial Cells for Next-Generation Sequencing
09:59

Isolation of Murine Retinal Endothelial Cells for Next-Generation Sequencing

Published on: October 11, 2021

3.0K
A Method for Labeling Vasculature in Embryonic Mice
09:58

A Method for Labeling Vasculature in Embryonic Mice

Published on: October 7, 2011

15.4K

Área de la Ciencia:

  • Oncología Oncología.
  • La inmunoterapia es una inmunoterapia.
  • Biología Molecular Biología Molecular

Sus antecedentes:

  • La inmunoterapia contra el factor de crecimiento endotelial anti-vascular (VEGF) del cáncer es una estrategia clave dirigida a la angiogénesis tumoral.
  • La resistencia a las terapias anti-VEGF es un desafío clínico significativo, que limita la eficacia del tratamiento.
  • Comprender los mecanismos de resistencia es crucial para desarrollar tratamientos más efectivos contra el cáncer.

Objetivo del estudio:

  • Aclarar los mecanismos por los cuales la galectina-1 contribuye a la resistencia en la inmunoterapia contra el cáncer anti-VEGF.
  • Investigar el papel de la galectina-1 en la regulación del receptor 2 del VEGF (VEGFR2) y la angiogénesis tumoral.
  • Identificar nuevos objetivos terapéuticos para superar la resistencia a los tratamientos anti-angiogénesis.

Principales métodos:

  • Investigó la interacción entre galectina-1 y VEGFR2 en las superficies de las células cancerosas.
  • Utilizó técnicas de biología molecular para estudiar la retención de VEGFR2 en la superficie celular.
  • Se evaluó el impacto de la galectina-1 en la angiogénesis tumoral independiente del VEGF en modelos preclínicos.

Principales resultados:

  • Se encontró que la galectina-1 prolonga la retención en la superficie celular de VEGFR2.
  • Esta retención prolongada estimula la angiogénesis tumoral independientemente del VEGF.
  • Identificó una compleja interacción de mecanismos que contribuyen a la resistencia terapéutica.

Conclusiones:

  • La galectina-1 juega un papel crítico en la promoción de la angiogénesis tumoral y la resistencia al tratamiento anti-VEGF.
  • Dirigirse a la galectina-1 o a sus efectos posteriores podría ser una estrategia prometedora para superar la resistencia.
  • Este estudio revela nuevos conocimientos sobre la base molecular de la resistencia en la inmunoterapia contra el cáncer.